Richel, D J <br/><br/>
The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.  [electronic resource] 

 -  British journal of cancer  Jul 1991 
 - 144-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1991.258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Amsacrine--administration & dosage<br/>Antigens, CD--analysis<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Azacitidine--administration & dosage<br/>Bone Marrow--pathology<br/>Decitabine<br/>Drug Resistance<br/>Female<br/>Humans<br/>Leukemia--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence